Header Logo

Annette Langer-Gould

Concepts (334)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Sclerosis
57
2024
97
23.730
Why?
Immunologic Factors
14
2021
27
4.450
Why?
Breast Feeding
13
2020
133
4.400
Why?
Multiple Sclerosis, Relapsing-Remitting
14
2021
16
4.180
Why?
Pregnancy Complications
14
2020
196
3.600
Why?
Rituximab
14
2024
15
3.240
Why?
Humans
91
2024
17611
2.970
Why?
Female
68
2024
12608
2.420
Why?
Vitamin D
5
2018
76
2.210
Why?
Postpartum Period
8
2023
94
2.150
Why?
Neurology
4
2021
6
2.110
Why?
Adult
47
2024
7598
2.060
Why?
Vitamin D Deficiency
4
2018
21
1.990
Why?
Male
42
2024
10008
1.720
Why?
Retrospective Studies
18
2024
2447
1.670
Why?
Pregnancy
22
2023
1494
1.620
Why?
Recurrence
9
2023
186
1.560
Why?
Middle Aged
29
2024
7911
1.410
Why?
Young Adult
19
2024
2427
1.400
Why?
Immunosuppressive Agents
6
2023
20
1.300
Why?
Hispanic Americans
7
2019
404
1.240
Why?
Sunlight
2
2018
13
1.220
Why?
Abnormalities, Drug-Induced
4
2016
15
1.200
Why?
Natalizumab
10
2023
10
1.200
Why?
Glatiramer Acetate
6
2020
6
1.180
Why?
Adrenal Cortex Hormones
4
2022
68
1.170
Why?
Interferon-beta
6
2020
6
1.130
Why?
Registries
10
2023
471
1.120
Why?
Antibodies, Monoclonal
6
2020
20
1.120
Why?
Ethnic Groups
4
2014
485
1.080
Why?
Antibodies, Monoclonal, Humanized
6
2020
24
1.070
Why?
Disease Progression
4
2021
264
1.020
Why?
Demyelinating Autoimmune Diseases, CNS
2
2015
7
0.990
Why?
Neuromyelitis Optica
2
2021
2
0.970
Why?
Cohort Studies
15
2023
2570
0.960
Why?
Hepatitis B Vaccines
2
2015
43
0.960
Why?
Anti-N-Methyl-D-Aspartate Receptor Encephalitis
1
2024
1
0.940
Why?
Phenotype
1
2024
149
0.940
Why?
Interleukin 1 Receptor Antagonist Protein
2
2022
12
0.930
Why?
Agammaglobulinemia
1
2024
2
0.930
Why?
Genetic Predisposition to Disease
3
2024
368
0.930
Why?
Drugs, Essential
1
2023
1
0.920
Why?
Biosimilar Pharmaceuticals
1
2023
1
0.920
Why?
Fingolimod Hydrochloride
5
2023
5
0.910
Why?
Health Status Disparities
2
2024
146
0.910
Why?
Disabled Persons
2
2015
35
0.900
Why?
Anti-Inflammatory Agents
2
2020
25
0.900
Why?
Papillomavirus Vaccines
2
2015
113
0.880
Why?
Family
1
2024
111
0.860
Why?
Vaccination
3
2022
635
0.850
Why?
Pseudotumor Cerebri
2
2013
3
0.850
Why?
Demyelinating Diseases
2
2013
3
0.820
Why?
Infant, Newborn, Diseases
2
2020
34
0.810
Why?
Incidence
10
2024
1255
0.800
Why?
Pregnancy Outcome
3
2023
154
0.800
Why?
Obesity
3
2013
837
0.800
Why?
Vaccines
2
2015
212
0.790
Why?
Access to Information
1
2021
13
0.790
Why?
California
12
2024
2284
0.780
Why?
Awards and Prizes
1
2021
9
0.770
Why?
Cytokines
2
2020
30
0.760
Why?
Social Determinants of Health
1
2021
37
0.760
Why?
Withholding Treatment
1
2021
26
0.740
Why?
Adolescent
13
2024
3651
0.730
Why?
Nervous System Diseases
3
2019
19
0.700
Why?
Betacoronavirus
1
2020
35
0.700
Why?
Risk Factors
10
2019
3325
0.690
Why?
Cognition Disorders
1
2020
31
0.690
Why?
Coronavirus Infections
1
2020
49
0.670
Why?
Gene-Environment Interaction
1
2019
21
0.670
Why?
Pneumonia, Viral
1
2020
56
0.670
Why?
Quality Improvement
1
2021
189
0.650
Why?
Risk
6
2017
516
0.650
Why?
Environmental Exposure
1
2019
116
0.630
Why?
Health Services Accessibility
1
2021
289
0.620
Why?
Immunoglobulin G
3
2024
29
0.620
Why?
Vitamin D-Binding Protein
1
2018
4
0.610
Why?
Polymorphism, Genetic
1
2018
62
0.600
Why?
African Continental Ancestry Group
2
2018
162
0.600
Why?
Cytomegalovirus
1
2017
3
0.590
Why?
Herpesvirus 4, Human
1
2017
6
0.590
Why?
United States
10
2023
3956
0.590
Why?
Child
10
2023
2474
0.580
Why?
Antibodies, Viral
1
2017
65
0.570
Why?
Medication Reconciliation
2
2013
5
0.550
Why?
Contraceptives, Oral, Combined
1
2016
5
0.530
Why?
Case-Control Studies
7
2021
1115
0.530
Why?
Estriol
1
2015
2
0.530
Why?
Leukoencephalopathy, Progressive Multifocal
2
2006
2
0.530
Why?
Peptides
2
2014
12
0.520
Why?
Prevalence
7
2023
884
0.510
Why?
Disease Management
2
2013
135
0.500
Why?
Emigration and Immigration
1
2015
15
0.490
Why?
Crotonates
1
2014
1
0.490
Why?
Toluidines
1
2014
1
0.490
Why?
Cross-Sectional Studies
5
2024
1322
0.470
Why?
Propylene Glycols
1
2014
1
0.460
Why?
Sphingosine
1
2014
1
0.460
Why?
Aged
11
2024
6095
0.450
Why?
Continental Population Groups
2
2013
302
0.450
Why?
Magnetic Resonance Imaging
6
2021
103
0.450
Why?
Spinal Cord Injuries
1
2013
5
0.450
Why?
Premature Birth
4
2023
137
0.450
Why?
Hospital Mortality
3
2022
145
0.440
Why?
Residence Characteristics
2
2015
248
0.430
Why?
Hospitalization
4
2022
797
0.430
Why?
Academies and Institutes
2
2023
7
0.420
Why?
Interferon-gamma
3
2010
8
0.410
Why?
T-Lymphocytes
2
2010
8
0.390
Why?
Dietary Supplements
3
2018
87
0.390
Why?
Prospective Studies
6
2020
1267
0.390
Why?
Puerperal Disorders
2
2020
9
0.380
Why?
Infant, Newborn
8
2023
844
0.380
Why?
European Continental Ancestry Group
4
2019
529
0.370
Why?
Milk, Human
2
2020
7
0.360
Why?
Infant
6
2024
1171
0.350
Why?
Autoimmune Diseases
1
2010
20
0.350
Why?
Immune Tolerance
1
2010
6
0.350
Why?
Pregnancy Trimesters
1
2010
30
0.340
Why?
Clinical Trials as Topic
3
2012
130
0.340
Why?
Aquaporin 4
1
2009
2
0.340
Why?
Diet
2
2022
365
0.330
Why?
Patient Selection
2
2012
190
0.330
Why?
Socioeconomic Factors
3
2017
630
0.330
Why?
Age Factors
3
2020
917
0.320
Why?
Time Factors
4
2020
1086
0.320
Why?
JC Virus
2
2006
2
0.320
Why?
Integrin alpha4
2
2006
2
0.320
Why?
African Americans
3
2021
472
0.310
Why?
HLA-DRB1 Chains
2
2019
13
0.310
Why?
Encephalomyelitis, Autoimmune, Experimental
3
2002
3
0.300
Why?
Prognosis
3
2021
606
0.280
Why?
Disability Evaluation
3
2015
46
0.270
Why?
Neurotoxicity Syndromes
1
2006
3
0.270
Why?
Child, Preschool
5
2014
1409
0.270
Why?
Lactation
2
2020
52
0.250
Why?
Abortion, Spontaneous
2
2016
47
0.250
Why?
Opportunistic Infections
1
2005
7
0.250
Why?
Longitudinal Studies
3
2013
710
0.250
Why?
Teratoma
1
2024
1
0.240
Why?
Sweden
5
2021
19
0.220
Why?
Cognitive Dysfunction
1
2024
47
0.220
Why?
Ovarian Neoplasms
1
2024
49
0.220
Why?
Respiratory Insufficiency
1
2023
17
0.220
Why?
Noninvasive Ventilation
1
2023
11
0.220
Why?
Blindness
1
2022
5
0.210
Why?
Dexamethasone
1
2022
12
0.210
Why?
Treatment Outcome
3
2020
1259
0.210
Why?
Infusions, Intravenous
2
2021
10
0.210
Why?
Sex Factors
2
2020
643
0.210
Why?
Pregnancy, Animal
1
2002
1
0.210
Why?
Suppressor Factors, Immunologic
1
2002
1
0.210
Why?
Food
1
2022
30
0.210
Why?
Diagnosis, Computer-Assisted
2
2019
6
0.210
Why?
Antibodies, Monoclonal, Murine-Derived
3
2011
3
0.200
Why?
Bibliometrics
1
2021
3
0.200
Why?
Surveys and Questionnaires
2
2017
1309
0.200
Why?
Risk Assessment
2
2021
1097
0.200
Why?
Medical Records
2
2019
100
0.200
Why?
Logistic Models
2
2017
926
0.200
Why?
Pandemics
2
2022
287
0.190
Why?
Alleles
2
2019
84
0.190
Why?
Educational Status
2
2020
200
0.190
Why?
Leadership
1
2021
39
0.190
Why?
Seasons
2
2012
102
0.190
Why?
Brain
3
2013
45
0.190
Why?
Body Mass Index
2
2018
958
0.190
Why?
Diet Surveys
1
2021
57
0.180
Why?
Disease Susceptibility
2
2016
37
0.180
Why?
Fruit
1
2021
79
0.180
Why?
Algorithms
2
2019
233
0.180
Why?
Early Medical Intervention
1
2020
10
0.180
Why?
Verbal Behavior
1
2020
2
0.180
Why?
Psychomotor Performance
1
2020
4
0.180
Why?
Follow-Up Studies
3
2020
1210
0.180
Why?
Neuropsychological Tests
1
2020
38
0.170
Why?
Polymorphism, Single Nucleotide
2
2019
373
0.170
Why?
Severity of Illness Index
1
2021
454
0.170
Why?
Feeding Behavior
1
2021
166
0.170
Why?
Child Development
1
2020
54
0.170
Why?
Family Planning Services
1
2019
20
0.170
Why?
Secondary Prevention
2
2014
47
0.160
Why?
Pharmacoepidemiology
1
2019
18
0.160
Why?
Pregnancy Trimester, Third
2
2020
17
0.160
Why?
Chronic Disease
2
2021
428
0.160
Why?
Transcription Factors
1
2019
19
0.160
Why?
Models, Theoretical
1
2019
70
0.160
Why?
Primary Health Care
1
2024
766
0.150
Why?
Histocompatibility Antigens Class II
1
2018
3
0.150
Why?
Ultraviolet Rays
1
2018
6
0.150
Why?
Genotyping Techniques
1
2018
26
0.150
Why?
Prenatal Exposure Delayed Effects
1
2020
160
0.150
Why?
Epstein-Barr Virus Nuclear Antigens
1
2017
2
0.150
Why?
Hygiene
1
2017
4
0.150
Why?
Genotype
1
2018
227
0.150
Why?
Reproductive Physiological Phenomena
1
2017
3
0.150
Why?
Regression Analysis
2
2019
297
0.150
Why?
Emigrants and Immigrants
1
2017
27
0.140
Why?
Smoking
1
2019
483
0.140
Why?
Analysis of Variance
2
2015
159
0.130
Why?
Progestins
1
2016
25
0.130
Why?
Societies, Medical
2
2013
74
0.130
Why?
Body Height
1
2016
62
0.130
Why?
Pregnancy Trimester, First
1
2016
39
0.130
Why?
Cesarean Section
1
2016
30
0.130
Why?
Neoplasms
1
2020
438
0.120
Why?
Databases, Factual
2
2019
309
0.120
Why?
Pregnancy Complications, Hematologic
1
2014
2
0.120
Why?
Colitis, Ulcerative
1
2014
9
0.120
Why?
Crohn Disease
1
2014
14
0.120
Why?
Statistics, Nonparametric
1
2013
50
0.110
Why?
Prepaid Health Plans
1
2013
20
0.110
Why?
B-Lymphocytes
2
2011
4
0.100
Why?
Animals
4
2014
259
0.100
Why?
Censuses
1
2012
31
0.100
Why?
Odds Ratio
2
2010
671
0.100
Why?
Hydroxycholecalciferols
1
2010
2
0.090
Why?
Prenatal Nutritional Physiological Phenomena
1
2010
5
0.090
Why?
Peptide Fragments
2
2002
27
0.090
Why?
Birth Certificates
1
2010
22
0.090
Why?
Medical Records Systems, Computerized
1
2010
85
0.090
Why?
Vitamins
1
2010
64
0.090
Why?
Amenorrhea
1
2010
3
0.090
Why?
Cell Count
1
2010
10
0.090
Why?
Down-Regulation
1
2010
13
0.090
Why?
Cell Proliferation
1
2010
19
0.090
Why?
CD4-Positive T-Lymphocytes
1
2010
13
0.090
Why?
Tumor Necrosis Factor-alpha
1
2010
27
0.090
Why?
Overweight
1
2012
269
0.090
Why?
Predictive Value of Tests
2
2010
351
0.090
Why?
Population Surveillance
1
2011
263
0.080
Why?
Kaplan-Meier Estimate
1
2009
129
0.080
Why?
Aged, 80 and over
1
2014
1900
0.080
Why?
Health Maintenance Organizations
1
2010
417
0.080
Why?
Mice
3
2002
68
0.070
Why?
Anal Canal
1
2006
7
0.070
Why?
Age of Onset
1
2006
79
0.070
Why?
Cell Migration Inhibition
1
2006
1
0.070
Why?
Data Interpretation, Statistical
1
2006
77
0.070
Why?
Fatal Outcome
1
2006
4
0.070
Why?
Diagnosis, Differential
1
2006
60
0.070
Why?
Germany
2
2016
14
0.070
Why?
Diagnostic Errors
1
2006
28
0.070
Why?
Delivery of Health Care, Integrated
1
2012
531
0.060
Why?
Antigens, CD20
2
2020
2
0.060
Why?
Aphasia
1
2005
1
0.060
Why?
Cytarabine
1
2005
1
0.060
Why?
Ataxia
1
2005
2
0.060
Why?
Paresis
1
2005
4
0.060
Why?
Mice, Inbred Strains
2
2002
4
0.060
Why?
Amino Acid Sequence
2
2002
9
0.060
Why?
Molecular Sequence Data
2
2002
17
0.060
Why?
Mitoxantrone
1
2004
2
0.060
Why?
Computers, Handheld
1
2024
11
0.060
Why?
Antiviral Agents
1
2005
94
0.060
Why?
Stakeholder Participation
1
2024
21
0.060
Why?
Research Design
1
2006
374
0.060
Why?
Pragmatic Clinical Trials as Topic
1
2024
57
0.060
Why?
Periaqueductal Gray
1
2003
1
0.060
Why?
Multiple Sclerosis, Chronic Progressive
1
2003
1
0.060
Why?
Aspartic Acid
1
2003
2
0.060
Why?
Magnetic Resonance Spectroscopy
1
2003
5
0.060
Why?
Oxygen
1
2023
16
0.050
Why?
Pharmaceutical Preparations
1
2023
11
0.050
Why?
Placenta
1
2023
20
0.050
Why?
Respiration, Artificial
1
2023
37
0.050
Why?
Population Control
1
2022
1
0.050
Why?
Dysgammaglobulinemia
1
2002
1
0.050
Why?
Th1 Cells
1
2002
1
0.050
Why?
Myelin Proteolipid Protein
1
2002
1
0.050
Why?
Adoptive Transfer
1
2002
1
0.050
Why?
Autoantigens
1
2002
2
0.050
Why?
Interleukin-2
1
2002
3
0.050
Why?
Cell Movement
1
2002
5
0.050
Why?
Transforming Growth Factor beta
1
2002
8
0.050
Why?
Lymphocyte Activation
1
2002
7
0.050
Why?
Interleukin-17
1
2002
1
0.050
Why?
Lymph Nodes
1
2002
17
0.050
Why?
Dementia
1
2024
106
0.050
Why?
Oligonucleotide Array Sequence Analysis
1
2002
23
0.050
Why?
Interleukin-6
1
2002
25
0.050
Why?
Medicare
1
2023
202
0.050
Why?
Anticoagulants
1
2022
127
0.050
Why?
Drug Administration Schedule
1
2021
98
0.050
Why?
Epitopes
1
1999
4
0.040
Why?
Ligands
1
1999
6
0.040
Why?
Bacterial Proteins
1
1999
13
0.040
Why?
Immunotherapy
1
2019
6
0.040
Why?
Geography, Medical
1
2019
4
0.040
Why?
Antirheumatic Agents
1
2019
11
0.040
Why?
HLA-A3 Antigen
1
2019
3
0.040
Why?
HLA-B7 Antigen
1
2019
3
0.040
Why?
Observer Variation
1
2019
37
0.040
Why?
Haplotypes
1
2019
34
0.040
Why?
Sensitivity and Specificity
1
2019
304
0.040
Why?
Asian Americans
1
2019
176
0.040
Why?
Genome-Wide Association Study
1
2019
243
0.040
Why?
Insurance, Health
1
2019
181
0.040
Why?
Anemia, Neonatal
1
2014
1
0.030
Why?
Leukocytosis
1
2014
5
0.030
Why?
Fetal Blood
1
2014
13
0.030
Why?
Thrombocytopenia
1
2014
15
0.030
Why?
Fetal Membranes, Premature Rupture
1
2014
11
0.030
Why?
Gestational Age
1
2014
111
0.030
Why?
Infant, Small for Gestational Age
1
2014
57
0.030
Why?
Mothers
1
2014
105
0.030
Why?
Maximum Tolerated Dose
1
2011
3
0.020
Why?
Family Characteristics
1
2012
54
0.020
Why?
Income
1
2012
90
0.020
Why?
Health Planning
1
2010
16
0.020
Why?
Data Collection
1
2012
256
0.020
Why?
Quality Control
1
2010
45
0.020
Why?
Health Services Research
1
2012
231
0.020
Why?
Poverty
1
2012
166
0.020
Why?
Confidence Intervals
1
2010
237
0.020
Why?
Healthcare Disparities
1
2010
201
0.020
Why?
Gadolinium
1
2008
1
0.020
Why?
Immunoglobulins
1
2008
3
0.020
Why?
Remission Induction
1
2008
25
0.020
Why?
Double-Blind Method
1
2008
155
0.020
Why?
Delivery of Health Care
1
2010
415
0.020
Why?
Osmolar Concentration
1
2003
8
0.010
Why?
Receptors, Fc
1
2002
1
0.010
Why?
Transcription, Genetic
1
2002
7
0.010
Why?
Granulocyte Colony-Stimulating Factor
1
2002
4
0.010
Why?
Mice, Inbred C57BL
1
2002
17
0.010
Why?
Autopsy
1
2002
15
0.010
Why?
Inflammation
1
2002
62
0.010
Why?
Acute Disease
1
2002
142
0.010
Why?
Reproducibility of Results
1
2002
381
0.010
Why?
Receptors, Antigen, T-Cell
1
1999
1
0.010
Why?
Cell Division
1
1999
5
0.010
Why?
Interleukin-4
1
1999
4
0.010
Why?
Myelin Basic Protein
1
1999
5
0.010
Why?
Concepts (334)
Explore
_
Co-Authors (18)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_
-->

© 2025 Kaiser Permanente